Effects of CALM intervention on neutrophil-to-lymphocyte ratio (NLR), fear of cancer recurrence and quality of life in patients with lung cancer

被引:5
|
作者
Zhao, Jie [1 ]
Wang, Menglian [1 ]
Huang, Runze [1 ]
Xu, Jian [1 ]
Gan, Chen [1 ]
Yu, Sheng [1 ]
Tang, Lingxue [1 ]
Yao, Senbang [1 ]
Li, Wen [1 ]
Cheng, Huaidong [1 ,2 ]
机构
[1] Anhui Med Univ, Affiliated Hosp 2, Dept Oncol, Hefei 230601, Anhui, Peoples R China
[2] Southern Med Univ, Shenzhen Hosp, Dept Oncol, Shenzhen 518000, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
CALM; Fear of cancer recurrence; NLR; Lung cancer; Quality of life; LIVING MEANINGFULLY CALM; MANAGING CANCER; DEPRESSION; DISTRESS; SYSTEM;
D O I
10.1007/s00520-023-07929-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeTo evaluate the feasibility and practicability of Managing Cancer and Living Meaningfully (CALM) as a psychological intervention to reduce neutrophil to lymphocyte ratio (NLR), fear of cancer recurrence, general distress, and improve quality of life in lung cancer survivors.MethodsEighty lung cancer patients with FCRI severity subscale (& GE;13 points) were recruited and randomly assigned to CALM or usual care (UC). NLR was recorded before and after treatment. The Fear of Cancer Recurrence Inventory (FCRI), Quality of Life Questionnaire Core 30 (QLQ-C30) and Depression-Anxiety-Stress Scale (DASS-21) were used to evaluate patients at baseline (T0), immediately after treatment (T1), and at 2 (T2) and 4 (T3) months.ResultsCompared with UC, NLR was significantly different before and after CALM intervention (z=-5.498; P=0.000). There were significant differences in the scores of QLQ, FCR and general distress before and after the T1, T2 and T3 interventions (F=220.30, F=315.20, F=290.10, respectively; P<0.001). NLR was negatively correlated with QOL both before (r=-0.763; P<0.0001) and after the intervention (r=-0.810, P<0.0001). FCR and general distress were negatively correlated with QOL in CALM (T0: r=-0.726, r=-0.776, respectively; P<0.0001; T1: r=-0.664, r=-0.647, respectively; P<0.0001; T2: r=-0.678, r=-0.695, respectively; P<0.0001; T3: r=-0.511, P = 0.0008; r=-0.650, P<0.0001).ConclusionCALM intervention can effectively reduce the NLR, alleviate the recurrence fear and general distress and improve the quality of life in patients. This study suggests that CALM may be an effective psychological intervention for reducing symptoms associated with lung cancer survivors.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Preoperative Neutrophil-to-Lymphocyte Ratio in Postmenopausal Breast Cancer Patients
    Ijichi, Hideki
    Tajiri, Wakako
    Koi, Yumiko
    Koga, Chinami
    Nakamura, Yoshiaki
    Okamoto, Masahiro
    Tokunaga, Eriko
    JOURNAL OF SURGICAL RESEARCH, 2024, 296 : 98 - 105
  • [32] Neutrophil-to-lymphocyte ratio and platelet distribution in patients with endometrial cancer
    Akin, Melike Nur
    Kasap, Burcu Harmandar
    Yuvaci, Hilal Uslu
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2015, 41 (09) : 1499 - 1499
  • [33] NEUTROPHIL-TO-LYMPHOCYTE RATIO AS A PREDICTOR OF OUTCOME IN OVARIAN CANCER PATIENTS
    McComiskey, M.
    Iavazzo, C.
    Datta, M.
    Winter-Roach, B.
    Smith, M.
    Slade, R.
    Ryan, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1437 - 1437
  • [34] The prognostic value of the neutrophil-to-lymphocyte ratio in patients with testicular cancer
    Bauza Quetglas, J. L.
    Tienza Fernandez, A.
    Bertolo, R.
    Sabate Arroyo, X. A.
    Guimera Garcia, J.
    Tubau Vidana, V.
    Frontera Juan, G.
    Pieras Ayala, E.
    PROGRES EN UROLOGIE, 2020, 30 (05): : 273 - 280
  • [35] Reproducibility of lymphocyte-to-monocyte ratio (LMR), neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in patients with locally advanced rectal cancer
    Gawinski, Cieszymierz
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [36] Pre-diagnosis neutrophil-to-lymphocyte ratio and lung cancer mortality
    Grieshober, Laurie
    Graw, Stefan
    Barnett, Matt J.
    Thornquist, Mark D.
    Goodman, Gary E.
    Chen, Chu
    Koestler, Devin
    Marsit, Carmen
    Doherty, Jennifer
    CANCER RESEARCH, 2019, 79 (13)
  • [37] Neutrophil-to-lymphocyte ratio as an indicator of prognosis in patients with pancreatic cancer
    Kawada, Tomoyuki
    HPB, 2019, 21 (12) : 1791 - 1791
  • [38] Derived Neutrophil-to-Lymphocyte Ratio as a Potential Biomarker for Lung Cancer Survival
    Imperato, A. E.
    Li, Y.
    Smith, R. L.
    Sauthoff, H.
    Felner, K.
    Segal, L. N.
    Sterman, D. H.
    Tsay, J. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [39] Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio help identify patients with lung cancer, but do not differentiate between lung cancer subtypes
    Nikolic, Igor
    Kukulj, Suzana
    Samarzija, Miroslav
    Jelec, Vjekoslav
    Zarak, Marko
    Orehovec, Biserka
    Taradi, Ida
    Romic, Dominik
    Kolak, Toni
    Patrlj, Leonardo
    CROATIAN MEDICAL JOURNAL, 2016, 57 (03) : 287 - 292
  • [40] Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab
    Diem, Stefan
    Schmid, Sabine
    Krapf, Mirjam
    Flatz, Lukas
    Born, Diana
    Jochum, Wolfram
    Templeton, Arnoud J.
    Fruh, Martin
    LUNG CANCER, 2017, 111 : 176 - 181